Skip to main content
Wolfson Institute of Population Health

Dr Oleg Blyuss


Reader in Data Science and Statistics



I am Reader in Data Science and Statistics at the Centre for Cancer Screening, Prevention and Early Diagnosis. My research is around development of predictive models that use multi-omic data for the early detection of cancer. Current grants aim at the analysis of longitudinal data arising from serum biomarkers and MRI images, which allows for a personalised approach in early detection. I hold a PhD in Applied Mathematics from Oles Honchar Dnipro National University, Ukraine.


Research Interests:

•    Predictive modelling
•    Machine learning
•    Longitudinal data analysis
•    Medical statistics
•    Early detection of cancer
•    Cancer biomarkers
•    Fuzzy clustering


Please follow through to see a complete list of Oleg's publications.

  1. N. Sushentsev, L. Rundo, L. Abrego, Z. Li, T. Nazarenko, A.Y. Warren, V.J. Gnanapragasam, E. Sala, A. Zaikin, T. Barrett, O. Blyuss, Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance.European Radiology. (2023).
  2. O. Blyuss, A. Dibden, N.J. Massat, D. Parmar, J. Cuzick, S.W. Duffy, P. Sasieni. A
    case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England. Cancer Medicine. (2022).
  3. T. Nazarenko, H.J. Whitwell, O. Blyuss, A. Zaikin, Parenclitic and Synolytic networks revisited. Frontiers in Genetics. (2021).
  4.  O. Blyuss, A. Zaikin, V. Cherepanova, D. Munblit, E.M. Kiseleva, O.M. Prytomanova,
    S.W. Duffy, T. Crnogorac-Jurcevic, Development of PancRISK, a urine biomarker-based
    risk score for stratified screening of pancreatic cancer patients. British Journal of Cancer. (2020).
  5.  O. Blyuss, M. Burnell, A. Ryan, A. Gentry-Maharaj, I. Marino, J. Kalsi, R. Manchanda,
    J.F. Timms, M. Parmar, S. Skates, I. Jacobs, A. Zaikin, U. Menon, Comparison of longitudinal CA125 algorithms as first-line screen for ovarian cancer in the general population, Clinical Cancer Research. (2018).
Back to top